Firsts Home

Equity & Derivatives Companies, sectors, M&A and the financial industry
Reuters ahead with BostonScientific sale plans; shares jump 04.08.2010 Reuters was alone on April 8 with the news that Boston Scientific hired an adviser to sell its neurovascular business and its pain management operations to raise cash. The headlines sent shares of Boston Scientific up as much as 7 percent in after-hours trading before they slipped back. JPMorgan, Wachovia and Leerink Swann analysts put out research reports on the news, citing Reuters. Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here	firsts across any industry Commodities & Energy Energy, metals, agricultural and environmental markets FX & Money Markets Macroeconomics, monetary policy, FX and money markets Politics & Risk Politics and political risk Equity & Derivatives Companies, sectors, M&A and the financial industry Fixed Income Sovereign and corporate debt, credit, and ratings firsts by region Americas View stories from this region Europe / Middle East / Africa View stories from this region Asia View stories from this region Emerging Markets View stories from this region

Equity & Derivatives

Companies, sectors, M&A and the financial industry

Reuters ahead with BostonScientific sale plans; shares jump

04.08.2010

Reuters was alone on April 8 with the news that Boston Scientific hired an adviser to sell its neurovascular business and its pain management operations to raise cash. The headlines sent shares of Boston Scientific up as much as 7 percent in after-hours trading before they slipped back. JPMorgan, Wachovia and Leerink Swann analysts put out research reports on the news, citing Reuters.

Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here